I. A. Otrishko

I. A. Otrishko

Auto-generated profile, based on publicly available information

I. A. Otrishko

Національний фармацевтичний університет Міністерства охорони здоров’я України

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2022 in Фармацевтичний часопис
Verified
Journal Article
Open access
PDF file
KZKateryna Zupanets
Kateryna Zupanets
TST. S. Sakharova
T. S. Sakharova
NBN. P. Bezugla
N. P. Bezugla
IOI. A. Otrishko
I. A. Otrishko
Sergii ShebekoSergii Shebeko
Sergii Shebeko
KRKseniia Ratushna
Kseniia Ratushna
Мета роботи. Оптимізація та удосконалення фармацевтичної опіки для забезпечення раціональної фітотерапії пацієнтів при симптоматичному лікуванні кашлю із застосуванням рослинних препаратів, отриманих за оригінальною технологією фітонірингу. Матеріали і методи. Методологічну основу дослідження складають принципи об’єктивності і системності. У роботі використано комплекс загальнонаукових та спеціальних методів: теоретичний, метод узагальнення, систематизації даних, порівняння, методи вивчення літературних джерел і аналізу та ін. Результати й обговорення. У роботі висвітлено основні принципи фармацевтичноїопіки пацієнтів із кашлем. Актуалізовано роль фітотерапії в симптоматичному лікуванні кашлю та обґрунтовано раціональний вибір оптимального препарату з позицій доказової медицини. Представлено алгоритм фармацевтичної опіки пацієнтів при симптоматичному лікуванні кашлю як одного з характерних симптомів запальних захворювань дихальних шляхів та алгоритм фармацевтичної опіки при виборі та відпуску стандартизованих фітопрепаратів у лікарській формі сиропу для симптоматичного лікування кашлю в дітей. Висновки. Під час проведення фармацевтичної опіки пацієнтів із кашлем першорядна рекомендація фармацевтом стандартизованих рослинних лікарських засобів ґрунтується на вагомих даних доказової медицини щодо їх ефективності і безпеки, а також прийнятності для застосування різними категоріями споживачів, включно дітей.

19 March 2021 in Clinical pharmacy
Verified
Journal Article
Open access
PDF file
TST.S. Sakharova
T.S. Sakharova
KZKateryna Zupanets
Kateryna Zupanets
IOI.A. Otrishko
I.A. Otrishko
NBN.P. Bezugla
N.P. Bezugla
KRKseniia Ratushna
Kseniia Ratushna
Diseases of the respiratory system occupy an important place in the structure of morbidity in the population of Ukraine, being only second to diseases of the cardiovascular system in prevalence. Patients with a respiratory pathology make up a significant part of the pharmacy visitors. In most cases, at the first symptoms of such diseases, patients begin to be treated on their own with the help of non-prescription drugs, and quite often the first person they turn to is a pharmacist. A striking example of the effectiveness and safety of herbal medicine is the symptomatic treatment of cough as one of the most characteristic symptoms of the respiratory tract pathology. The use of herbal products with the antitussive, expectorant, mucolytic action has a long history, and currently it does not lose its significance. The clinical efficacy of herbal products is determined by the mechanism of their specific action, and the rational choice of the optimal drug taking into account the cause of the cough, its nature and the characteristics of the course of the inflammatory process in the respiratory organs, allows eliminating cough or effectively managing it. Bronchipret® is a herbal product of “Bionorica SE” company, which is one of the most studied and widely used in medical practice. The drug is indicated for the treatment of respiratory tract diseases accompanied by cough and sputum formation, including acute and chronic bronchitis. The main and well-studied pharmacological effects of Bronchipret® are secretolytic/mucolytic, anti-inflammatory, antiviral, antimicrobial and bronchospasmolytic ones. The pharmacological effects listed are due to a complex of biologically active substances (BAS) of such plants as the root of spring primrose, thyme herb, ivy leaf. All medicinal plants that make up the “active core” of the drug have a long history of their use in folk medicine. Moreover, their various beneficial effects on the human body in different diseases and conditions have been confirmed by empirical experience. The drug is produced in three dosage forms (drops, syrup, tablets), and it determines the targeting of its prescription to different categories of patients. The drug has a high evidence base and has been studied at the cellular and molecular levels. Conclusions. In the case of choosing a herbal medicine for responsible self-medication, drug consumers can rely on their own experience, but most of them trust the knowledge of a pharmaceutical professional, and this fact increases the pharmacist’s responsibility for the treatment prescribed. Therefore, it should be the choice of a drug with an optimal efficacy/safety ratio, which is determined from the standpoint of evidence-based medicine. It is precisely these requirements that the phytoneering drug Bronchipret® meets.

19 May 2023 in Social Pharmacy in Health Care
Verified
Journal Article
Open access
PDF file
OPO. S. Popov
O. S. Popov
VDV. Ye. Dobrova
V. Ye. Dobrova
IOI. A. Otrishko
I. A. Otrishko
Aim. To assess whether Ukrainian clinical research professionals’ self-assessment of their GCP knowledge matches their actual (tested) GCP knowledge; to assess actual GCP knowledge in populations with different experience level, role in clinical trials, and number of attended GCP trainings; to assess whether short-term GCP trainings suffice for adequate professional level in GCP domain. Materials and methods. We developed a questionnaire which consisted of the following parts: demographic data, self-assessment of core competencies, tests on the basic issues of ICH GCP and assessment of the necessity for additional training. Data were analysed by using of description statistical methods and Kruskal-Wallis, Chi-square, Fisher exact test, and Mann-Whitney tests. Statistical analyses were performed using Statistica StatSoft software, Version 8.0 (StatSoft Power Solution Inc.). Results. We received 216 questionnaires with answers; some questionnaires were not fully completed and did not have answers to key questions of the study. Therefore, in the analysis, we included only 186 properly done questionnaires. Conclusions. Respondents' self-assessment of their competence level in GCP properly matches the test results. Experience level did not substantially influence GCP knowledge. Regardless of experience level, the respondents demonstrated a low level of knowledge for the questions "randomization purpose according to ICH GCP" and "monitoring purposes according to ICH GCP". Both the group with high self-perceived competence and the group with low self-perceived competence demonstrated the level of knowledge above 70% for all other questions. Respondents of the group, which brought together representatives of the regulatory authority, research ethics committees and contract research organizations had slightly better results than other clinical research professionals. The number of trainings attended did not affect the quality of knowledge demonstrated by respondents. Thus, an in-depth long-term academic training for clinical research professionals is warranted and is a possible topic for future research. Key words: clinical research competence domains; good clinical practice; clinical research professionals; professional development; self-assessment; clinical trials

3 April 2026 in Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії
Verified
Journal Article
Open access
IOI. A. Otrishko
I. A. Otrishko
KVK. V. Vietrova
K. V. Vietrova
NBN. P. Bezugla
N. P. Bezugla
TST. S. Sakharova
T. S. Sakharova
KSK. O. Shelest
K. O. Shelest
B vitamins occupy an important place in the comprehensive treatment of pain syndromes, both acute and chronic. Aim of the study – to determine the role of the pharmacist in improving treatment adherence among individuals using B-complex vitamins. Materials and Methods. The results of a questionnaire survey of 20 pharmacy visitors who sought to purchase medicines containing B-complex vitamins were analyzed. Results. The most common reasons for the use of medicines containing B-vitamin complex were peripheral neuritis caused by: neuropathy due to compression (16 patients, 80.00%); metabolic disorders (diabetes mellitus – 3 patients (15.00%), chronic alcohol consumption – 1 patient (5.00%). The most common manifestation of neuropathy reported by respondents was pain (16 respondents, 80.00%); muscle weakness was noted by 3 respondents (15.00%); numbness of the extremities by 7 respondents (35.00%); edema by 2 respondents (10.00%); and gait/balance disturbances by 1 respondent (5.00%). For the treatment of pain syndrome in cases of compression, medicines containing B-group vitamin complex in parenteral dosage forms (Milgamma®, Neurorubin™, Neurobion, etc.) were predominantly prescribed, followed by a transition to oral formulations. In cases of long-term treatment of diabetic polyneuropathy in patients with diabetes mellitus and neuropathy of alcoholic origin, preference was also given to medicines in oral dosage forms (Neurorubin™-Forte Lactab; Neurobex-Teva; Neurobion; Neuromultivit®). According to respondents, the factors that positively influenced treatment adherence included: rapid reduction of pain syndrome (80.00% of respondents); a convenient dosing regimen (once daily) – 80.00% of respondents; and 20.00% of respondents with comorbid conditions noted the possibility of combined use of B-vitamin complex medicinal products with drugs from other pharmacological groups prescribed by a physician for the treatment of concomitant pathology. The main factors contributing to the absence or reduction of compliance with pharmacotherapy, according to respondents, were: painful injections (12 patients, 60.00%); adverse reactions (20.00% of respondents); violations of the dosing regimen and storage conditions (20.00% of respondents); and 70.00% considered the cost of treatment to be relatively high. Conclusions. Pharmaceutical care in the use of vitamin B complex is aimed at ensuring the efficacy, safety and appropriateness of their use.

1 April 2026 in Social Pharmacy in Health Care
Verified
Journal Article
Open access
IOI. A. Otrishko
I. A. Otrishko
КVК. V. Vietrova
К. V. Vietrova
NBN. P. N. P. Bezugla
N. P. N. P. Bezugla
TST. S. Sakharova
T. S. Sakharova
TZT. S. Zhulai
T. S. Zhulai
KSK. О. Sukhanova
K. О. Sukhanova
Intestinal dysbiosis is a pressing issue in modern medicine and pharmacy due to the high prevalence of intestinal microflora disorders among the population and their significant impact on overall health, well-being, and the effectiveness of treatment of concomitant diseases. Aim. To assess the importance of pharmaceutical care as an effective mechanism for ensuring the effectiveness of antidiarrheal microbial medicines for the prevention and treatment of intestinal dysbiosis. Materials and methods. The research materials were the questionnaire-based survey among 30 pharmacy visitors who applied to pharmacies to purchase antidiarrheal microbial medicines for the prevention and treatment of intestinal dysbiosis. The methodological basis of the study consists of the principles of objectivity and consistency. The work uses a set of general scientific and special methods, such as theoretical, generalization, data systematization, comparison, methods of studying literary sources, analysis, questionnaires, etc. Results and discussion. To correct dysbacteriosis, respondents most often chose antidiarrheal microbial medicines based on lactobacilli and their combinations (Linex, Linex Forte, Lactovit Forte, Yoghurt) – 18 persons (60.00 %), Bacillus clausii (Enterozhermina) – 10 persons (33.30 %), and Saccharomyces boulardii (Enterol, Normagut) – 12 persons (40.00 %). Some pharmacy visitors combined different medicines to achieve the best pharmacotherapeutic results. Antidiarrheal microbial medicines in the dosage form of hard capsules were chosen by 20 respondents (66.70 %). For adults, this dosage form is more convenient and provides the stability of active microorganisms, as well as the ease of administration. Oral suspensions were used by 10 respondents (33.30 %), usually in cases of difficulties with swallowing capsules. The treatment compliance among respondents was generally high: 18 people (60.00 %) adhered strictly to the regimen, 9 persons (30.00 %) adhered moderately, and only 3 persons (10.00 %) showed low compliance, which was associated with forgetfulness or unauthorized changes to the course of treatment. Conclusions. Providing proper pharmaceutical care is an effective mechanism for ensuring the effectiveness of anti-diarrheal microbial medicines for the prevention and treatment of intestinal dysbiosis. And the pharmacist, as an active participant in the pharmacotherapy of dysbacteriosis, is able to contribute to the prevention of dysbiotic manifestations, reduce the frequency and severity of dysbacteriosis, and improve the quality of life. The process of improving pharmaceutical care for intestinal dysbiosis should be ongoing, based on the latest technological solutions and scientifically sound approaches to the treatment of dysbiotic conditions, harmonized with the latest achievements in modern gastroenterology.

19 March 2021 in Clinical pharmacy
Verified
Journal Article
Open access
PDF file
SMS. V. Misiurova
S. V. Misiurova
NSN. O Svid
N. O Svid
VDV. Ye Dobrova
V. Ye Dobrova
IOI. A Otrishko
I. A Otrishko
VPV. V. Propisnova
V. V. Propisnova
The main principles of creating a quality system in modern laboratory diagnostics are: standardization of laboratory processes by developing standard operating procedures; general quality management of laboratory research based on the development and implementation of the requirements of international standards (according to ISO 15189: 2015 "Medical laboratories. Basic requirements for quality and competence"); quality control of all stages of the laboratory process through the implementation of the validation procedure. Aim. To develop a methodology for conducting validation procedures to assess the suitability of a biochemical method for determining the level of total cholesterol in biological fluids in the Clinical Diagnostic Laboratory of the Clinical Diagnostic Center of the NUPh. Materials and methods. The object of the study was a standardized method for determining the concentration of total cholesterol. The method was validated using the “Cholesterol Reagent Set” test kit and the standard sample “Chemical control. Reagent kit. Level 1 ", manufactured by High Technology, Inc. (USA) with known concentration. The measurements were carried out on an Express Plus automatic biochemical analyzer manufactured by Bayer Corporation, Germany. When processing the research results, descriptive statistics were used and a number of statistical evaluations were carried out. Results. A protocol and a validation report were developed at the Clinical Diagnostic Laboratory of the CDC NUPh to assess the suitability of the method for determining the concentration of cholesterol in biological fluids by the photometric enzymatic method on an automatic biochemical analyzer Express Plus (using reagents and control material manufactured by High Technology, Inc., USA). The validation characteristics of the method were determined: repeatability and reproducibility, correctness and uncertainty of measurements. Evaluation of the internal laboratory repeatability and reproducibility of this technique indicates the absence of gross errors in the operation of the instrument and statistically important differences in measurements. The assessment of the correctness of the method (carried out using the control material) proved that the systematic error is not significant (according to a given acceptance criterion). The expanded uncertainty calculation showed that the obtained values ​​of the total cholesterol level can be considered accurate and reliable. Conclusions. Validation of the method for determining total cholesterol in human blood by the photometric enzymatic method has proven that this method has performance characteristics that correspond to the regulated ones, meets the established criteria, and the parameters measured with it correspond to the proper ones. Key words: validation, determination method, total cholesterol, repeatability and reproducibility, correctness and uncertainty of measurements